Skip to main content
Premium Trial:

Request an Annual Quote

Curtis Rosebraugh, Bruce Stillman

Premium
The US Food and Drug Administration announced the appointment last week of Curtis Rosebraugh as the new director of the Office of Drug Evaluation II. Prior to joining FDA in 2000 as a medical officer in the Division of Pulmonary and Allergy Drugs Products, Rosebraugh was an assistant professor of internal medicine at the University of Kansas-Wichita and later an assistant professor of internal medicine and internal medicine clerkship director at the University of Texas Medical Branch-Galveston. From 2003 to 2005, he served as the deputy director of the Office of Nonprescription Products and was acting director of the Division of Nonprescription Clinical Evaluation in the same office. In 2005, Rosebraugh became deputy director of the Office of Drug Evaluation II and became acting director of the office in September 2007.
 

 
Cold Spring Harbor Laboratory President Bruce Stillman has been elected to the American Academy of Arts and Sciences. Stillman has been director of the CSHL Cancer Center since 1994 and he has been president since 2003.

Filed under

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.